NCT04168411

Brief Summary

Fracture of the base of the fifth metatarsal is one of the most common injuries in ankle trauma. There are many conservative treatment protocols for fifth metatarsal base fractures which have up to 99% success. Short leg cast and walking boot are conservative treatment methods that aim to prevent weight-bearing. There are many different conservative treatment methods that allow weight-bearing such as an elastic bandage. There was no significant difference between cast and symptomatic treatment in the previous studies. Muscle atrophy developing after immobilization with cast may adversely affect the daily activities of the patient in the first few months. However, there was no study comparing the effect of these two treatment methods on ankle muscle strength. In this study, the investigators compared the strength of the ınjured and healthy ankle muscle when symptomatic and cast treatment methods are applied to patients with tuberosity fractures of proximal fifty metatars. In addition, patients' functional, clinic and radiological outcomes were also compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 19, 2019

Completed
Last Updated

November 19, 2019

Status Verified

November 1, 2019

Enrollment Period

1.2 years

First QC Date

November 13, 2019

Last Update Submit

November 17, 2019

Conditions

Keywords

metatarsal, fracture, muscle weakness, isokinetic test,

Outcome Measures

Primary Outcomes (1)

  • Changed of Baseline Isokinetic Muscle Strength at 6 months

    Both ankle plantar-dorsiflexion muscle strength and inversion-eversion muscle strength (peak torque %BW (Body Weight)) were measured with an isokinetic dynamometer (Cybex Humac Norm, CA, USA) at Isokinetic Test Laboratory of Sports Medicine in the Istanbul Medical Faculty. Test procedure was performed by the same investigator in all cases for ensuring standardization. The muscle strength can be defined as the capacity of a muscle to withstand great force. Injured extremity values were compared with healthy extremity. he healthy extremity was measured at initial injury time for evaluation of side effect of both treatment methods.

    Isokinetic Muscle Strength test was scheduled for baseline, 4, 8,12 and 24 week intervals to assess ankle muscle strength

Secondary Outcomes (2)

  • Changed of Baseline VAS-FA Scores at 6 months

    baseline, 2, 4, 8,12 and 24 weeks follow-up visit

  • Changed of Baseline EuroQol-5D VAS Scores at 6 months

    baseline, 2nd, 4th, 8th,12th and 24th week follow-up visit

Other Outcomes (4)

  • Number of Days with using an assistive device

    through study completion, an average of 6 months

  • Number of Days with a take of analgesia

    through study completion, an average of 6 months

  • Number of Days with unable to work

    through study completion, an average of 6 months

  • +1 more other outcomes

Study Arms (2)

Symptomatic treatment group

EXPERIMENTAL

The patients were allocated to wear a double layered elasticated bandage for treatment 5th metatarsal base fractures (Zone 1).

Procedure: Symptomatic Treatment

Cast group

ACTIVE COMPARATOR

The patients were given a below-knee cast for treatment 5th metatarsal base fractures (Zone 1).

Procedure: Symptomatic Treatment

Interventions

Conservative treatment methods of tuberosity fractures of the proximal fifth metatarsal

Cast groupSymptomatic treatment group

Eligibility Criteria

Age21 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged over 18 years
  • Acute (presented within one week of injury) Zone 1 fractures of fifth metatarsi

You may not qualify if:

  • Zone 2-3 fractures
  • Diabetes mellitus
  • Osteoporotic bone (T score\<-2.5),
  • History of osteoporotic drug therapy,
  • Other lower extremity any fracture,
  • Previous foot surgery or fracture in both lower extremity,
  • Chronic fracture, pathological fracture,
  • Aged over 65 years (congruity of muscle strength test)
  • Open fracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University, Istanbul Faculty of Medicine

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscle WeaknessFractures, Bone

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsWounds and Injuries

Study Officials

  • Turgut Akgul, MD

    Istanbul University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

November 13, 2019

First Posted

November 19, 2019

Study Start

April 15, 2018

Primary Completion

June 20, 2019

Study Completion

September 9, 2019

Last Updated

November 19, 2019

Record last verified: 2019-11

Locations